Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hojman

Showing results (191-200 of 197) with videos related to

Pageof 20
Sort By:
You have reached the last page of results.This site can display upto 197 results.
Journal of Medicinal Chemistry|August 12, 2021
Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 BiologyTimo Heinrich, Ada Sala-Hojman, Roberta Ferretti, et al.
Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2025
Carbapenem-resistant Gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort studyJuan Pablo Balbuena, Ezequiel Cordova, Analia Mykietiuk, et al.
Cancer Letters|December 10, 2025
Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinomaNathalie Babl, Florian Voll, Agnieszka Martowicz, et al.
Journal of Sport and Health Science|September 28, 2024
Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in miceMarit Hjorth, Casey L Egan, Guilherme D Telles, et al.
Journal of Medicinal Chemistry|September 17, 2025
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 InhibitorSam E Mann, Julien Lefranc, Omar Alkhatib, et al.
American Journal of Obstetrics & Gynecology MFM|February 23, 2021
Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019Francesco D'Antonio, Cihat Sen, Daniele Di Mascio, et al.
Pageof 20

Showing results (191-200 of 197) with videos related to

Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 197 results.
Journal of Medicinal Chemistry|August 12, 2021
Discovery of 5-{2-[5-Chloro-2-(5-ethoxyquinoline-8-sulfonamido)phenyl]ethynyl}-4-methoxypyridine-2-carboxylic Acid, a Highly Selective in Vivo Useable Chemical Probe to Dissect MCT4 BiologyTimo Heinrich, Ada Sala-Hojman, Roberta Ferretti, et al.
Nucleic Acids Research|December 8, 2025
Mechanistic insights into the monotherapy and combination potential of FEN1 inhibition in cancer therapyEeson Rajendra, Claudio A Lademann, Bethany Mason, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2025
Carbapenem-resistant Gram-negative bacilli bacteremia in Argentina (EMBARCAR): findings from a prospective, multicenter cohort studyJuan Pablo Balbuena, Ezequiel Cordova, Analia Mykietiuk, et al.
Cancer Letters|December 10, 2025
Lactic acid promotes an MDSC-like phenotype via HIF1α stabilization with impact on prognosis in renal cell carcinomaNathalie Babl, Florian Voll, Agnieszka Martowicz, et al.
Journal of Sport and Health Science|September 28, 2024
Decorin, an exercise-induced secretory protein, is associated with improved prognosis in breast cancer patients but does not mediate anti-tumorigenic tissue crosstalk in miceMarit Hjorth, Casey L Egan, Guilherme D Telles, et al.
Journal of Medicinal Chemistry|September 17, 2025
Fragment-Based Discovery and Structure-Led Optimization of MSC778, the First Potent, Selective, and Orally Bioavailable FEN1 InhibitorSam E Mann, Julien Lefranc, Omar Alkhatib, et al.
American Journal of Obstetrics & Gynecology MFM|February 23, 2021
Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019Francesco D'Antonio, Cihat Sen, Daniele Di Mascio, et al.
Pageof 20